Clinical trial
Effect of Anti-diabetic Drugs on Glycemic Variability. A Comparison Between Gliclazide MR (Modified Release) and Dapagliflozin on Glycemic Variability Measured by Continuous Glucose Monitoring (CGM) in Patients With Uncontrolled Type 2 Diabetes
NCT02925559 is registered in ClinicalTrials.gov with Centro de Diabetes Curitiba Ltda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Anti-diabetic Drugs on Glycemic Variability. A Comparison Between Gliclazide MR (Modified Release) and Dapagliflozin on Glycemic Variability Measured by Continuous Glucose Monitoring (CGM) in Patients With Uncontrolled Type 2 Diabetes
- Lead sponsor
- Centro de Diabetes Curitiba Ltda
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- January 31, 2019
- Enrollment
- 135 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.